Anti-VEGF Receptor 3 Antibody [LY322856] Biosimilar - BSA and Azide free (A339724)

Name: Anti-VEGF Receptor 3 Antibody [LY322856] Biosimilar - BSA and Azide free
Brand: Antibodies.com
SKU: A339724
Price: 370.0 GBP
Availability: InStock

Enlarge Image

$518

Human monoclonal antibody to VEGF Receptor 3. Research grade Anti-Human FLT4 [LY3022856] biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

100% Guarantee

Price Match Guarantee

Shipping Information

Freight/Packing Charges: $40

Dispatched from St. Louis, MO.

Lead Time: 7-10 business days.

Specifications

Name

Anti-VEGF Receptor 3 Antibody [LY322856] Biosimilar - BSA and Azide free

Description

Human monoclonal antibody to VEGF Receptor 3. Research grade Anti-Human FLT4 [LY3022856] biosimilar.

Applications

ELISA, Flow Cytometry, Functional Studies, in vivo Research

Reactivity

Human

Host

Human

Clonality

Monoclonal

Clone ID

LY322856

Isotype

IgG1

Conjugate

Unconjugated

Purity

The purity of this Biosimilar is >95%, as determined by SDS-PAGE.

Product Form

Liquid

Formulation

Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.

Storage

Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).

Synonyms

FLT-4, FLT4, Fms-like tyrosine kinase 4, Tyrosine-protein kinase receptor FLT4, Vascular endothelial growth factor receptor 3, VEGFR-3, VEGFR3

Suitable Secondaries

See all Anti-Human IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (1)

Enlarge Image

SDS-PAGE - Anti-VEGF Receptor 3 Antibody [LY322856] Biosimilar - BSA and Azide free (A339724)

SDS-PAGE for Anti-VEGF Receptor 3 Antibody [LY322856] Biosimilar - BSA and Azide free (A339724).

Publishing research using Anti-VEGF Receptor 3 Antibody [LY322856] Biosimilar - BSA and Azide free (A339724)? Please let us know so that we can list the citation on this page.